Logo-ipp

Immunopathol Persa. 2019;5(2): e22. doi: 10.15171/ipp.2019.22

Original

Administration of vitamin D to ameliorate dyspnea of chronic obstructive pulmonary disease patients: a randomized controlled trial

Samad Ghodrati 1 ORCID, Arian Ezzatpanah 1, Masoud Asadi-Khiavi 3,4, Shohreh Alian Samakkah 5, Abdolreza Esmaeilzadeh 6, Aiyoub Pezeshgi 1,2 * ORCID

Cited by CrossRef: 2

1- rezaei nejad S, bakhshi aliabad H, basirat H, maleki H, amin F, karimi M. correlation between serum Vitamin D3 Level and Disease Severity in the Patients with Chronic Obstructive Pulmonary Disease (COPD). SJKU. 2024;28(6):65 [Crossref]
2- Goodarzi V, Nouri S, Nassaj Z, Bighash M, Abbasian S, Hagh R. Long non coding RNAs reveal important pathways in childhood asthma: a future perspective. J Mol Histol. 2023;54(4):257 [Crossref]
3- Li M, Zhao L, Hu C, Li Y, Yang Y, Zhang X, Li Q, Ma A, Cai J. Improvement of Lung Function by Micronutrient Supplementation in Patients with COPD: A Systematic Review and Meta-Analysis. Nutrients. 2024;16(7):1028 [Crossref]
4- Saleem A, Sharif S, Jarvis S, Madouros N, Koumadoraki E, Khan S. A Comprehensive Review on Vitamin D as a Novel Therapeutic Agent in Chronic Obstructive Pulmonary Disease. 2021; [Crossref]